Allied Research International (ARI) is a member of the Cetero Research Family the leading provider of early clinical, bioanalytical and niche late stage research services. ARI is a full service CRO specializing in early and late stage clinical trial conduct and management. Our Toronto, Canada and Miami, USA campuses have a combined 213-bed capacity for Phase I/IIa studies, and are ideal sites for Phase II-IV clinical trials. ARI is a leader in allergy and respiratory research with our focused therapeutic experience and unique models developed and validated in our own Environmental Exposure Chambers.
From Phase I to IV, ARI offers comprehensive services including scientific and regulatory consultation, protocol development, quality assurance, data management, PK/PD/statistics, and medical writing.